Institutional & Family Asset Management, LLC Abbott Laboratories Transaction History

Institutional & Family Asset Management, LLC

$846 Million
Q2 2024

A detailed history of Institutional & Family Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Institutional & Family Asset Management, LLC holds 37,004 shares of ABT stock, worth $4.2 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

37,004

Previous 37,816 2.15%

Holding current value

$4.2 Million

Previous $4.3 Million 10.54%

% of portfolio

0.45%

Previous 0.52%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 05, 2024	SELL	$100.73 - $112.44 $81,792 - $91,301	-812 Reduced 2.15%	37,004 $3.85 Million
Q1 2024 May 08, 2024	SELL	$109.52 - $120.96 $328,121 - $362,396	-2,996 Reduced 7.34%	37,816 $4.3 Million
Q4 2023 Feb 06, 2024	SELL	$90.19 - $110.4 $15,151 - $18,547	-168 Reduced 0.41%	40,812 $4.49 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $27,321 - $32,781	286 Added 0.7%	40,980 $3.97 Million
Q2 2023 Aug 09, 2023	SELL	$100.78 - $112.29 $671,295 - $747,963	-6,661 Reduced 14.07%	40,694 $4.44 Million
Q1 2023 May 08, 2023	BUY	$96.86 - $114.01 $190,620 - $224,371	1,968 Added 4.34%	47,355 $4.8 Million
Q4 2022 Feb 08, 2023	SELL	$95.06 - $111.52 $9,125 - $10,705	-96 Reduced 0.21%	45,387 $4.98 Million
Q3 2022 Nov 07, 2022	BUY	$96.76 - $112.03 $751,051 - $869,576	7,762 Added 20.58%	45,483 $4.4 Million
Q2 2022 Aug 08, 2022	BUY	$102.07 - $123.37 $153,819 - $185,918	1,507 Added 4.16%	37,721 $4.1 Million
Q1 2022 May 11, 2022	BUY	$114.02 - $139.04 $69,438 - $84,675	609 Added 1.71%	36,214 $4.29 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $832,162 - $1.02 Million	-7,203 Reduced 16.83%	35,605 $5.01 Million
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $269,251 - $297,870	-2,308 Reduced 5.12%	42,808 $5.06 Million
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $779,778 - $917,910	7,371 Added 19.53%	45,116 $5.23 Million
Q1 2021 May 06, 2021	BUY	$108.84 - $128.23 $218,441 - $257,357	2,007 Added 5.62%	37,745 $4.52 Million
Q4 2020 Feb 03, 2021	BUY	$105.0 - $114.42 $344,715 - $375,640	3,283 Added 10.12%	35,738 $3.91 Million
Q3 2020 Oct 30, 2020	SELL	$91.64 - $111.29 $930,695 - $1.13 Million	-10,156 Reduced 23.83%	32,455 $3.53 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $319,603 - $409,052	-4,174 Reduced 8.92%	42,611 $3.9 Million
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $229,167 - $335,105	3,648 Added 8.46%	46,785 $3.69 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $324,717 - $361,486	-4,136 Reduced 8.75%	43,137 $3.75 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $195,924 - $212,443	-2,394 Reduced 4.82%	47,273 $3.96 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $75,139 - $87,635	-1,031 Reduced 2.03%	49,667 $4.18 Million
Q1 2019 May 13, 2019	SELL	$66.22 - $80.06 $54,234 - $65,569	-819 Reduced 1.59%	50,698 $4.05 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $654,682 - $741,660	-9,986 Reduced 16.24%	51,517 $3.73 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $36,850 - $44,456	-606 Reduced 0.98%	61,503 $4.51 Million
Q2 2018 Aug 13, 2018	SELL	$57.57 - $63.54 $180,654 - $199,388	-3,138 Reduced 4.81%	62,109 $3.79 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $651,494 - $736,592	-11,578 Reduced 15.07%	65,247 $3.91 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $397,661 - $425,737	-7,408 Reduced 8.79%	76,825 $4.38 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $55,365 - $61,793	1,152 Added 1.39%	84,233 $4.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	83,081	83,081 $4.04 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Account

Institutional & Family Asset Management, LLC Abbott Laboratories Transaction History